8-KMaterial AgreementsFinancial EventsExhibits & Filings

HCA Healthcare, Inc. 8-K Report, Material Agreement (Apr 26, 2012)

Filed April 26, 2012For Securities:HCA

Summary

HCA Healthcare, Inc. (HCA) has filed a Form 8-K detailing an amendment to its existing credit agreement. The primary focus of this filing is the extension of the maturity date for a significant portion of its outstanding term loans. Specifically, the company has converted approximately $74.6 million in tranche A-1 term loans and $651.2 million in tranche B-1 term loans into new tranche A-3 term loans, pushing their maturity to February 2, 2016. This amendment provides HCA with extended financial flexibility and a longer runway for these specific debt obligations. Investors should note that other terms, commitments, and outstanding letters of credit under the credit agreement remain unchanged. The filing indicates a proactive approach by HCA to manage its debt structure and ensure continued access to capital.

Key Highlights

  • 1HCA Healthcare amended its credit agreement on April 25, 2012, via Extension Amendment No. 1.
  • 2The amendment extends the maturity date for approximately $74.6 million of tranche A-1 term loans and $651.2 million of tranche B-1 term loans.
  • 3These loans have been converted into new tranche A-3 term loans with a maturity date of February 2, 2016.
  • 4The interest margins for the new tranche A-3 term loans are set at 2.25% for ABR and 3.25% for LIBOR.
  • 5All other loans, commitments, and letters of credit under the original credit agreement remain unchanged.
  • 6The filing signifies a strategic move by HCA to manage its debt maturity profile and enhance financial flexibility.

Frequently Asked Questions

The main purpose of this 8-K filing is to announce an amendment to HCA Healthcare's existing credit agreement. This amendment specifically extends the maturity date for a substantial portion of the company's term loans.

Approximately $74.6 million of tranche A-1 term loans and $651.2 million of tranche B-1 term loans are affected. These have been converted into new tranche A-3 term loans, which now mature on February 2, 2016. The interest margins for these new loans are 2.25% (ABR) and 3.25% (LIBOR).

No, this amendment specifically addresses the tranche A-1 and tranche B-1 term loans mentioned. All other loans, commitments, and outstanding letters of credit under the credit agreement remain unchanged.

By extending the maturity of these significant debt tranches, HCA is enhancing its financial flexibility and providing itself with a longer period to manage these obligations before they come due. This suggests a proactive approach to debt management.